Cargando…
IGF1–PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity
Heart failure represents the end point of a variety of cardiovascular diseases. It is a growing health burden and a leading cause of death worldwide. To date, limited treatment options exist for the treatment of heart failure, but exercise has been well-established as one of the few safe and effecti...
Autores principales: | Bass-Stringer, Sebastian, Tai, Celeste M.K., McMullen, Julie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai University of Sport
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724616/ https://www.ncbi.nlm.nih.gov/pubmed/33246162 http://dx.doi.org/10.1016/j.jshs.2020.11.009 |
Ejemplares similares
-
Crucial role of androgen receptor in resistance and endurance trainings-induced muscle hypertrophy through IGF-1/IGF-1R- PI3K/Akt- mTOR pathway
por: YIN, Lijun, et al.
Publicado: (2020) -
Chronic Contractile Dysfunction without Hypertrophy Does Not Provoke a Compensatory Transcriptional Response in Mouse Hearts
por: Matkovich, Scot J., et al.
Publicado: (2016) -
Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing
por: Daley, Mark C., et al.
Publicado: (2023) -
Regulation of PI3K and Hand2 gene on physiological hypertrophy of heart following high-intensity interval, and endurance training
por: Gharaat, Mohammad Ali, et al.
Publicado: (2019) -
Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway
por: Zhan, Lan, et al.
Publicado: (2021)